Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    MannKind Corporation

    NASDAQ: MNKD · Real-Time Price · USD
    3.81
    0.08 (2.14%)
    At close: Aug 18, 2025, 3:59 PM
    3.80
    -0.39%
    After-hours: Aug 18, 2025, 07:59 PM EDT
    2.14%
    Bid 3.78
    Market Cap 1.17B
    Revenue (ttm) 297.6M
    Net Income (ttm) 30.12M
    EPS (ttm) 0.11
    PE Ratio (ttm) 34.68
    Forward PE 20.68
    Analyst Buy
    Ask 3.82
    Volume 2,000,252
    Avg. Volume (20D) 2,945,438
    Open 3.75
    Previous Close 3.73
    Day's Range 3.74 - 3.85
    52-Week Range 3.38 - 7.63
    Beta 1.02

    About MNKD

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol MNKD
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for MNKD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    MannKind Corporation is scheduled to release its earnings on Nov 6, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    8 months ago
    +8.73%
    MannKind shares are trading higher after Wells Far... Unlock content with Pro Subscription
    news image

    1 week ago · seekingalpha.com

    MannKind Corporation (MNKD) Q2 2025 Earnings Conference Call Transcript

    MannKind Corporation (NASDAQ:MNKD ) Q2 2025 Earnings Call August 6, 2025 9:00 AM ET Company Participants Christopher B. Prentiss - Chief Financial Officer Michael E.

    news image

    1 week ago · seekingalpha.com

    MannKind Corporation: A Post-Q2 Assessment

    Today, we take another look at MannKind Corporation, which specializes in inhaled therapeutics for endocrine and orphan lung diseases, with a market cap of $1.15 billion. The company just reported sec...

    news image

    1 week ago · zacks.com

    MannKind (MNKD) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

    The headline numbers for MannKind (MNKD) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimate...

    news image

    1 week ago · zacks.com

    MannKind (MNKD) Reports Break-Even Earnings for Q2

    MannKind (MNKD) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.04. This compares to earnings of $0.05 per share a year ago.

    news image

    2 weeks ago · zacks.com

    Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for

    MannKind (MNKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    2 months ago · seekingalpha.com

    MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition

    MannKind's stock decline is likely due to concerns over Tyvaso DPI competition from Liquidia, but I believe these fears are exaggerated. Tyvaso DPI provides MannKind with a stable revenue base, suppor...

    Add to Watchlist